Literature DB >> 173912

The effect of danazol in sexual precocity.

P A Lee, R G Thompson, C J Migeon, R M Blizzard.   

Abstract

The effect of Danazol, a synthetic 2,3 isoxazol derivative of 17 alpha-ethinyl testosterone, was assessed in three girls and two boys with sexual precocity. Progression of sexual development ceased during administration of Danazol; the effect upon growth rate and skeletal maturation was equivocal. Serum estrogen and progesterone concentrations in the girls were lower during treatment; serum testosterone and dehydroepiandrosterone levels in the boys were also lower. Serum and urinary luteinizing hormone concentrations were inconsistently suppressed. No effect upon follicle-stimulating hormone levels could be demonstrated. Although Danazol appears to inhibit sexual development, this study indicates that the pituitary-gonadal axis is not completely suppressed. Growth rate is not reverted to normal, and virilization may occur among girls. Because undesirable side effects may outweight desirable results, careful consideration is recommended before Danazol is prescribed in the management of sexual precocity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173912

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


  5 in total

1.  Effects of danazol on steroidogenesis and gonadotropic responsiveness in isolated human preovulatory follicular cells.

Authors:  J H Olsson; B Dennefors; L Nilsson
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

2.  The child with precocious puberty.

Authors:  S R Marks; M J Elders
Journal:  J Natl Med Assoc       Date:  1979-02       Impact factor: 1.798

3.  Danazol-beta-cyclodextrin binary system: a potential application in emergency contraception by the oral route.

Authors:  Ganesh S Jadhav; Pradeep R Vavia; Tarala D Nandedkar
Journal:  AAPS PharmSciTech       Date:  2007-05-11       Impact factor: 3.246

Review 4.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

5.  Cyproterone acetate treatment in precocious puberty.

Authors:  R Lorini; A Colombo; A G Ugazio; A Salvatoni; M Cisternino; D Larizza; E Polito; V Monafo; M Bozzola; F Severi
Journal:  J Endocrinol Invest       Date:  1981 Jul-Sep       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.